Robotics Prosthetics Market – Hypothesis Investigation Report 2027

This report provides in depth study of “Robotics Prosthetics Market 2017 Global Industry Research Report focuses on industry chain structure, market Size, Share, opportunities, future roadmap, industry analysis, industry policy analysis, market Leading player profiles and strategies. This New Report presented by Market Research Futurecontains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. Further MRFR asserts that the Market will demonstrate a colossal growth by 2027.

Competition in the Global Robotics Prosthetics Market and are profiled in MRFR Analysis. “Global Robotics Prosthetics Market by Manufacturers, Countries, Type and Application, Forecast to 2027 Report “Provides In-Depth Analysis Of Parent Market Trends, Macro-Economic Indicators And Governing Factors Along With Market Attractiveness As Per Segments.

Key Players in the Robotics Prosthetics Market:

The global robotics prosthetics market is highly fragmented with the presence of many Local Players and International Players. The main focus of these players is cost reduction and innovation to ensure sustainability. In addition, the international players implemented growth strategies through collaborations and partnerships to expand their overall market share.

“ReWalk Robotics Ltd. Plans To Regain Compliance With Nasdaq” On November 10, 2017, ReWalk Robotics Ltd. (the “Company”) received a notification letter (the “Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company failed to comply with the minimum $2,500,000 stockholders’ equity requirement for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(b), and did not meet the alternative $35,000,000 market value of listed securities standard (“MVLS”) and $500,000 net income standard requirements.

“Medrobotics Corporation Receives FDA Clearance for Flex Robotic System for Scarfree™ Colorectal Procedures” Medrobotics Corp. announced it has received FDA regulatory clearance to market the Flex® Robotic System for colorectal procedures in the United States. Medrobotics is the first and only company to offer minimally invasive, steerable and shapeable robotic products for colorectal procedures in the U.S. The Flex® Robotic System is the world’s first robotic surgical platform to offer Scarfree™ access to hard-to-reach anatomy in otolaryngology and colorectal procedures.

In healthcare, robots are now most widely used for various purposes such as surgery. The demand for robotic prosthetic is found to be increasing across the globe, especially in the developed countries of Americas and Europe. Increasing number of amputation cases, as a result of severe injuries to various body parts drives the market. Furthermore, the rising prevalence of obesity, diabetes, vascular disease, stroke, and arthritis also contribute to the increasing number of amputation cases.

According to the estimates published by the Amputee Coalition, approximately 185,000 amputations are performed in the U.S each year. According to the EksoZeroG, in 2015, 625,000 occupational injuries occurred in the manufacturing and construction industries and the U.S. alone spends USD 21 billion per year on workplace-related injuries that drains productivity.

Additionally, the market is expected to show extensive growth in Asia Pacific regions, especially in China. International Diabetes Federation stated that about 420 million adult population worldwide was suffering from diabetes in 2016, which is increasing at the rate of 8.4% per year and is expected to reach 625 million by 2040.

As per the Lancet study, China, and India have high diabetic population as compared to other Asian countries. The number of diabetic population in China has increased from 20.4 million in 1980 to 102.9 million in 2014. In India, the diabetic population roused from 11.9 million in 1980 to 64.5 million in 2014. Prevalence of diabetes has more than doubled for men in India and China and 50% among women in China and 80% among women in India.

Key developments:

Strategic approaches adopted helped the major players in the market to sustain their growth and develop their business in various geographical areas across the globe. Agreements and collaborations, mergers and acquisitions, and new product launches are various strategies followed by the key players.

HDT Global:

HDT Global, headquartered in the US, is a robotics prosthetics manufacturing company. It is the first company to develop an electrically powered prosthetic hand with five independently powered fingers and the company continues to be a pioneer in upper limb prosthetics.

Touch Bionics Inc. and Touch Bionics Limited:

Touch Bionics Inc. and Touch Bionics Limited. Is a leading provider of prosthetic technologies and supporting services designed to ensure the best possible outcomes for people with upper limb deficiencies. i- ultra is the major product manufacture by the company.

May, 2016: Touch Bionics Inc. and Touch Bionics Limited. introduced digitally controlled supro wrist. It is based on i-mo technology in conjunction with our new digital electrodes, which helps to move both wrist and fingers simultaneously to perform a particular task with free movement.

SynTouch, LLC:

SynTouch, LLC is a company that offer various product under robotic prosthetics, and sensor technology. The major products offered by the company are hand prosthetics for patients that have under gone amputation. BioTac and BioTac SP sensors are the most popular biomimetic tactile devices used across the world.

Market Growth in America:

There is an increasing demand for robotic prosthetics owing to increasing number of injuries in the U.S. and Canada as well as rising demand for technological advanced devices and equipment’s by healthcare institutes. According to the International Osteoporosis Foundation (2013), approximately 1.4 million Canadians and 44 million people in the US are suffering with either osteoporosis or low bone mass. Increasing awareness among the people towards the use of innovative technologies and high healthcare spending of the people has fuelled the market growth. The growth of medical device industry also accelerates the market, supported by innovative product development by key players in the market, and availability of medical technologies.

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Event Details

PULSUS group cordially welcomes researchers, academicians, students and business professionals in the field of Cancer Science and Therapy from around

more

Event Details

PULSUS group cordially welcomes researchers, academicians, students and business professionals in the field of Cancer Science and Therapy from around the world to participate in the upcoming “2nd World Congress on Advanced Cancer Science & Therapy” to be held at Dubai, UAE during January 28-29, 2019. The meeting for this year will revolve around the theme “An Assembly of Curious Facts and Cure for Cancer” thus relaying the most cutting-edge findings in this field.

The two-day meeting is going to be an event to look forward for its enlightening symposiums & workshops from established experts in cancer therapy, potential keynote talks from eminent speakers, informative oral sessions and innovative poster presentations.

Cancer Therapy 2019 is an extraordinary event that invites participants from different leading universities, clinical research institutions and various diagnostic companies to share their research experiences in all aspects of this rapidly expanding field and provides an opportunity to meet and communicate with leading doctors, surgeons, scientists, academic professionals from around the world and listen to top speakers on new developments that impact and advance future of cancer science. It serves as a global platform to know about the current developments and new approaches in the field of cancer science and therapy. It will also prove to be a brilliant open door for businesses keen on expanding their global market reach. This event is an effort to understand the underlying new techniques which are amended to increase effectiveness, accuracy, sustainability, and quality of life.